Phase II Study of Paclitaxel in Combination with Mitoxantrone and Ifosfamide/Mesna for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma after Failure to Cytarabine/Cisplatin Combination

被引：0
|
作者：
Jorge E. Romaguera
M. Alma Rodriguez
Fredrick B. Hagemeister
Peter McLaughlin
Jose Rodriguez
Alejandro Preti
Anas Younes
Andreas H. Sarris
Fernando Cabanillas
机构：
[1] University of Texas M.D. Anderson Cancer Center,Department of Lymphoma
来源：
Investigational New Drugs | 1999年 / 17卷
关键词：
relapsed NHL; paclitaxel; MINT chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose: Evaluate response, duration of response, and toxicity of paclitaxel in combination with other drugs known to be effective in non-Hodgkin's lymphoma (NHL).
引用
收藏
页码：187 / 192
页数：5
相关论文
共 50 条
  • [1] Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/Mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination
    Romaguera, JE
    Rodriguez, MA
    Hagemeister, FB
    McLaughlin, P
    Rodriguez, J
    Preti, A
    Younes, A
    Sarris, AH
    Cabanillas, F
    [J]. INVESTIGATIONAL NEW DRUGS, 1999, 17 (02) : 187 - 192
  • [2] Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or resistant or refractory non-Hodgkins lymphoma (NHL) failing a doxorubicin-containing regmien and a cytarabine/cisplatin-containing regimen.
    Romaguera, JE
    Rodriguez, MA
    Hagemeister, FB
    McLaughlin, P
    Rodriguez, J
    Preti, AH
    Younes, A
    Sarris, AH
    Cabanillas, F
    [J]. BLOOD, 1999, 94 (10) : 267B - 267B
  • [3] Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma
    Romaguera, JE
    Hagemeister, FB
    McLaughlin, P
    Rodriguez, MA
    Bachier, C
    Preti, H
    Sarris, AH
    Weber, D
    Younes, A
    Cabanillas, F
    [J]. LEUKEMIA & LYMPHOMA, 1998, 32 (1-2) : 97 - 106
  • [4] Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
    Mey, Ulrich J. M.
    Orlopp, Katjana S.
    Flieger, Dimitri
    Strehl, John W.
    Ho, Anthony D.
    Hensel, Manfred
    Bopp, Cordula
    Gorschlueter, Marcus
    Wilhelm, Martin
    Birkmann, Josef
    Kaiser, Ulrich
    Neubauer, Andreas
    Florschuetz, Axel
    Rabe, Christian
    Hahn, Corinna
    Glasmacher, Axel G.
    Schmidt-Wolf, Ingo G. H.
    [J]. CANCER INVESTIGATION, 2006, 24 (06) : 593 - 600
  • [5] Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma
    Seon-Kyeong Kim
    Moo-Kon Song
    Joo Seop Chung
    Ho-Jin Shin
    [J]. International Journal of Hematology, 2013, 98 : 543 - 548
  • [6] Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin's lymphoma
    Kim, Seon-Kyeong
    Song, Moo-Kon
    Chung, Joo Seop
    Shin, Ho-Jin
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (05) : 543 - 548
  • [7] A phase II trial of dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
    Mey, UJM
    Strehl, JW
    Orlopp, KS
    Flieger, D
    Birkmann, J
    Ho, A
    Kaiser, U
    Neubauer, A
    Glasmacher, AG
    Schmidt-Wolf, IGH
    [J]. BLOOD, 2004, 104 (11) : 238B - 238B
  • [8] Dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
    Mey, U
    Orlopp, K
    Flieger, D
    Strehl, J
    Ho, A
    Hensel, M
    Birkmann, J
    Wilhelm, M
    Kaiser, U
    Neubauer, A
    Glasmacher, A
    Schmidt-Wolf, I
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 180 - 180
  • [9] Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma
    Stamatoullas, A
    Fruchart, C
    Bastit, D
    Boulet, D
    Monconduit, M
    Piguet, H
    Tilly, H
    [J]. CANCER, 1996, 77 (11) : 2302 - 2307
  • [10] A gemcitabine, cisplatin and dexamethazone combination in patients with multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.
    Emmanouilides, C
    Territo, M
    [J]. BLOOD, 1999, 94 (10) : 261B - 261B
12345